This program was filmed during the year 2000 and covers the first clinical trials of
Endostatin in human patients. As of March 2002, 120 patients have received Endostatin,
with no side effects reported. There has also been enough biological effect to
justify continued testing. Today, taking Endostatin is much simpler than it was
when the film was produced. Many patients are self-injecting at home, as diabetics
do with insulin. The next phase of testing, which will begin to assess how effective
Endostatin is against cancer.
After six months, Duane Gay was removed from the Endostatin clinical trial.
His tumors had grown beyond the strict limit allowed by the University of Wisconsin's
Endostatin protocol.
He continues to battle his cancer with experimental therapies and hopes to get back on
Endostatin when a new protocol is available.
